Distinct expression of the soluble and the membrane-bound forms of interleukin-1 receptor accessory protein in the endometrium of women with endometriosis

Guay S, Sophie Guay, Nadège Michaud, Michaud N, Nathalie Bourcier, Bourcier N, Mathieu Lebœuf, Mathieu Leboeuf, Lemyre M, Madeleine Lemyre, Mailloux J, Jacques Mailloux, Akoum A, Ali Akoum
Fertility and sterility · 2011 · vol. 95(4) , pp. 1284–1290 · doi:10.1016/j.fertnstert.2010.12.056 · PMID:21272866 · W2039986866
article OA: closed CC0 ⤵ 10 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study investigated the differential expression of soluble and membrane-bound interleukin-1 receptor accessory protein in the endometrium of women with endometriosis compared to healthy controls.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo investigate interleukin (IL) 1 receptor accessory protein (IL1RAcP) expression in the eutopic endometrium of women with endometriosis.DesignRetrospective study.SettingHuman reproduction research laboratory.Patient(s)Sixty-six women with endometriosis and 60 healthy women with no laparoscopic evidence of endometriosis.Intervention(s)Endometrial tissue samples were obtained during laparoscopic surgery.Main outcome measure(s)IL1RAcP protein expression was analyzed by immunohistochemistry, Western blot, and ELISA, and IL1RAcP mRNA expression was analyzed by quantitative real-time polymerase chain reaction.Result(s)This study showed a significant downregulation of soluble (s)IL1RAcP expression in the eutopic endometrium of women with endometriosis compared to normal women, occurring at the protein or mRNA level. This finding appeared to vary according to endometriosis stage, being more obvious in the earliest (I and II) than the latest (III and IV) stages of the disease. However, the membrane-bound IL1RAcP did not show any noticeable endometriosis-related change, neither at the protein or mRNA level.Conclusion(s)In view of the wide spectrum of IL-1 inflammatory and growth-promoting effects, downregulation of sIL1RAcP, which is known for inhibiting IL1, indicates a profound defect in the capability of endometrial cells of women with endometriosis to counterregulate IL-1 effects and may represent an important mechanism underlying the ability of these cells to implant and develop into host tissues.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Cell Membrane Endometriosis Endometrium Gene Expression Regulation Interleukin-1 Receptor Accessory Protein Adult Cell Membrane Endometriosis Endometriosis Endometrium Endometrium Female Humans Interleukin-1 Receptor Accessory Protein Interleukin-1 Receptor Accessory Protein Protein Array Analysis Retrospective Studies Solubility Young Adult

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (52)

Cited by (10)

Source provenance

europepmc
last seen: 2026-09-27T09:11:36.575535+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:16:54.825375+00:00
License: CC0 · commercial use OK